VICKIE BROWNE: Open Payments
NPI 1982940797 · RIVERDALE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,893 in 82 payments from 16 companies in 2025. Trend: 2023 $1,265 · 2024 $1,587 · 2025 $1,893
Food & beverage: $1,893
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $289 |
| ABBVIE INC. | 15 | $275 |
| Ipsen Biopharmaceuticals, Inc | 6 | $251 |
| Janssen Biotech, Inc. | 10 | $180 |
| Lilly USA, LLC | 8 | $171 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $135 |
| GENZYME CORPORATION | 2 | $124 |
| Phathom Pharmaceuticals, Inc. | 4 | $111 |
| Madrigal Pharmaceuticals | 3 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $74 |
Products named: XIFAXAN, IQIRVO, DUPIXENT, TREMFYA, OMVOH, RINVOQ, ENTYVIO, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
